NewsBenzingaNeoGenomics : BPA ajusté du T3 à 0,07 $ dépasse l’estimation de 0,05 $, ventes à 209,254 M$ supérieures à l’estimation de 207,328 M$ NeoGenomics : BPA ajusté du T3 à 0,07 $ dépasse l’estimation de 0,05 $, ventes à 209,254 M$ supérieures à l’estimation de 207,328 M$ Benzinga 2026.10.28 20:11 (GMT+0) Open on Benzinga Other news Freedom Broker Maintains Buy on XPeng, Lowers Price Target to $20 Plug Power Shares Slide Toward 52-Week Low Despite New 280-MW Texas Deal Nvidia Vs. Anthropic: Can the AI IPO Challenge Nvidia’s Dominance Across ETFs? Freedom Broker Maintains Buy on Allot, Lowers Price Target to $12.7 Freedom Broker Upgrades M-Tron Industries to Buy, Lowers Price Target to $84 As decision model use skyrockets, is customization is the next frontier?